Two prominent gene-editing startups, Chroma Medicine and Nvelop Therapeutics, said Wednesday they will merge, forming a new company called nChroma Bio.
The merger will combine molecular machines Chroma was developing to modify genes without cutting DNA and technology Nvelop was developing to deliver DNA-modifying machinery to precise tissues in the body.
Leadership for the combined company argued it was a natural fit. In industry parlance, it joins a “delivery” company with a “cargo” company — fusing the two key pieces needed to build a genetic medicine.
Click this link for the original source of this article.
Author: Jason Mast
This content is courtesy of, and owned and copyrighted by, https://www.statnews.com and its author. This content is made available by use of the public RSS feed offered by the host site and is used for educational purposes only. If you are the author or represent the host site and would like this content removed now and in the future, please contact USSANews.com using the email address in the Contact page found in the website menu.
